Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages

Cyclooxygenase 2 (COX-2) plays a key role in the regulation of inflammation by catalyzing the oxygenation of PUFAs to prostaglandins (PGs) and hydroperoxides. Next to this, COX-2 can metabolize neutral lipids, including endocannabinoid-like esters and amides. We developed an LC-HRMS-based human recombinant (h)COX-2 screening assay to examine its ability to also convert n-3 PUFA-derived N-acylethanolamines. Our assay yields known hCOX-2-derived products from established PUFAs and anandamide. Subsequently, we proved that eicosapentaenoylethanolamide (EPEA), the N-acylethanolamine derivative of EPA, is converted into PGE3-ethanolamide (PGE3-EA), and into 11-, 14-, and 18-hydroxyeicosapentaenoyl-EA (11-, 14-, and 18-HEPE-EA, respectively). Interestingly, we demonstrated that docosahexaenoylethanolamide (DHEA) is converted by hCOX-2 into the previously unknown metabolites, 13- and 16-hydroxy-DHEA (13- and 16-HDHEA, respectively). These products were also produced by lipopolysaccharide-stimulated RAW267.4 macrophages incubated with DHEA. No oxygenated DHEA metabolites were detected when the selective COX-2 inhibitor, celecoxib, was added to the cells, further underlining the role of COX-2 in the formation of the novel hydroxylated products. This work demonstrates for the first time that DHEA and EPEA are converted by COX-2 into previously unknown hydroxylated metabolites and invites future studies toward the biological effects of these metabolites.

Saved in:
Bibliographic Details
Main Authors: de Bus, Ian, Zuilhof, Han, Witkamp, Renger, Balvers, Michiel, Albada, Bauke
Format: Article/Letter to editor biblioteca
Language:English
Subjects:cyclooxygenase, cyclooxygenase 2, fatty acid amides, fatty acid oxidation, high-performance liquid chromatography, inflammation, mass spectrometry, prostaglandins,
Online Access:https://research.wur.nl/en/publications/novel-cox-2-products-of-n-3-polyunsaturated-fatty-acid-ethanolami
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-555945
record_format koha
spelling dig-wur-nl-wurpubs-5559452025-01-16 de Bus, Ian Zuilhof, Han Witkamp, Renger Balvers, Michiel Albada, Bauke Article/Letter to editor Journal of Lipid Research 60 (2019) 11 ISSN: 0022-2275 Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages 2019 Cyclooxygenase 2 (COX-2) plays a key role in the regulation of inflammation by catalyzing the oxygenation of PUFAs to prostaglandins (PGs) and hydroperoxides. Next to this, COX-2 can metabolize neutral lipids, including endocannabinoid-like esters and amides. We developed an LC-HRMS-based human recombinant (h)COX-2 screening assay to examine its ability to also convert n-3 PUFA-derived N-acylethanolamines. Our assay yields known hCOX-2-derived products from established PUFAs and anandamide. Subsequently, we proved that eicosapentaenoylethanolamide (EPEA), the N-acylethanolamine derivative of EPA, is converted into PGE3-ethanolamide (PGE3-EA), and into 11-, 14-, and 18-hydroxyeicosapentaenoyl-EA (11-, 14-, and 18-HEPE-EA, respectively). Interestingly, we demonstrated that docosahexaenoylethanolamide (DHEA) is converted by hCOX-2 into the previously unknown metabolites, 13- and 16-hydroxy-DHEA (13- and 16-HDHEA, respectively). These products were also produced by lipopolysaccharide-stimulated RAW267.4 macrophages incubated with DHEA. No oxygenated DHEA metabolites were detected when the selective COX-2 inhibitor, celecoxib, was added to the cells, further underlining the role of COX-2 in the formation of the novel hydroxylated products. This work demonstrates for the first time that DHEA and EPEA are converted by COX-2 into previously unknown hydroxylated metabolites and invites future studies toward the biological effects of these metabolites. en application/pdf https://research.wur.nl/en/publications/novel-cox-2-products-of-n-3-polyunsaturated-fatty-acid-ethanolami 10.1194/jlr.M094235 https://edepot.wur.nl/506704 cyclooxygenase cyclooxygenase 2 fatty acid amides fatty acid oxidation high-performance liquid chromatography inflammation mass spectrometry prostaglandins https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic cyclooxygenase
cyclooxygenase 2
fatty acid amides
fatty acid oxidation
high-performance liquid chromatography
inflammation
mass spectrometry
prostaglandins
cyclooxygenase
cyclooxygenase 2
fatty acid amides
fatty acid oxidation
high-performance liquid chromatography
inflammation
mass spectrometry
prostaglandins
spellingShingle cyclooxygenase
cyclooxygenase 2
fatty acid amides
fatty acid oxidation
high-performance liquid chromatography
inflammation
mass spectrometry
prostaglandins
cyclooxygenase
cyclooxygenase 2
fatty acid amides
fatty acid oxidation
high-performance liquid chromatography
inflammation
mass spectrometry
prostaglandins
de Bus, Ian
Zuilhof, Han
Witkamp, Renger
Balvers, Michiel
Albada, Bauke
Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages
description Cyclooxygenase 2 (COX-2) plays a key role in the regulation of inflammation by catalyzing the oxygenation of PUFAs to prostaglandins (PGs) and hydroperoxides. Next to this, COX-2 can metabolize neutral lipids, including endocannabinoid-like esters and amides. We developed an LC-HRMS-based human recombinant (h)COX-2 screening assay to examine its ability to also convert n-3 PUFA-derived N-acylethanolamines. Our assay yields known hCOX-2-derived products from established PUFAs and anandamide. Subsequently, we proved that eicosapentaenoylethanolamide (EPEA), the N-acylethanolamine derivative of EPA, is converted into PGE3-ethanolamide (PGE3-EA), and into 11-, 14-, and 18-hydroxyeicosapentaenoyl-EA (11-, 14-, and 18-HEPE-EA, respectively). Interestingly, we demonstrated that docosahexaenoylethanolamide (DHEA) is converted by hCOX-2 into the previously unknown metabolites, 13- and 16-hydroxy-DHEA (13- and 16-HDHEA, respectively). These products were also produced by lipopolysaccharide-stimulated RAW267.4 macrophages incubated with DHEA. No oxygenated DHEA metabolites were detected when the selective COX-2 inhibitor, celecoxib, was added to the cells, further underlining the role of COX-2 in the formation of the novel hydroxylated products. This work demonstrates for the first time that DHEA and EPEA are converted by COX-2 into previously unknown hydroxylated metabolites and invites future studies toward the biological effects of these metabolites.
format Article/Letter to editor
topic_facet cyclooxygenase
cyclooxygenase 2
fatty acid amides
fatty acid oxidation
high-performance liquid chromatography
inflammation
mass spectrometry
prostaglandins
author de Bus, Ian
Zuilhof, Han
Witkamp, Renger
Balvers, Michiel
Albada, Bauke
author_facet de Bus, Ian
Zuilhof, Han
Witkamp, Renger
Balvers, Michiel
Albada, Bauke
author_sort de Bus, Ian
title Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages
title_short Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages
title_full Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages
title_fullStr Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages
title_full_unstemmed Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages
title_sort novel cox-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in raw264.7 macrophages
url https://research.wur.nl/en/publications/novel-cox-2-products-of-n-3-polyunsaturated-fatty-acid-ethanolami
work_keys_str_mv AT debusian novelcox2productsofn3polyunsaturatedfattyacidethanolamineconjugatesidentifiedinraw2647macrophages
AT zuilhofhan novelcox2productsofn3polyunsaturatedfattyacidethanolamineconjugatesidentifiedinraw2647macrophages
AT witkamprenger novelcox2productsofn3polyunsaturatedfattyacidethanolamineconjugatesidentifiedinraw2647macrophages
AT balversmichiel novelcox2productsofn3polyunsaturatedfattyacidethanolamineconjugatesidentifiedinraw2647macrophages
AT albadabauke novelcox2productsofn3polyunsaturatedfattyacidethanolamineconjugatesidentifiedinraw2647macrophages
_version_ 1822268382697750528